Oct 24, 2018 - While Allergan's (AGN) Q3 sales are likely to be driven by new as well as established products like Botox, generic competition for some key products is expected to hurt sales.
Oct 25, 2018 - Is (AMGN) Outperforming Other Medical Stocks This Year?
Oct 26, 2018 - We take a look at a few stocks that might deliver an earnings beat when they report next week.
Oct 26, 2018 - Glaxo's (GSK) is expected to see strong sales in its Vaccines business segment.
Oct 28, 2018 - Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks
Oct 29, 2018 - The Zacks Analyst Blog Highlights: Allergan, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and AMAG Pharmaceuticals
Oct 29, 2018 - The Cardio & Vascular product line to boost Integer Holdings' (ITGR) top line in Q3. The upside will be driven by strong revenues in the peripheral vascular, neurovascular and electrophysiology markets.
Oct 30, 2018 - Amgen (AMGN) delivered earnings and revenue surprises of 7.89% and 1.52%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Oct 30, 2018 - Facebook earnings beat by 30 cents from the Zacks consensus to $1.76 per share, and above the $1.59 in the year-ago quarter. However, revenues missed expectations of $13.81 billion, posting $13.73 billion, but are still up roughly 30% year over year.
Oct 30, 2018 - New drug launches weren't quite enough to offset losses posted by aging blockbusters.